COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Beyond Oil Expands Sales into Eastern Europe with 16 Ton Order from Franchisee of Global Fast-Food Chain
Beyond Oil announces major milestone in expanding global commercialization efforts with an order from a European fast-food chain, representing a significant step in disrupting the food oil industry worldwide -
COMMUNIQUÉ DE PRESSE
Northern Superior Reports 2.60 g/t Au Over 26.5 Metres Including 4.55 g/t Au Over 13.4 Metres, From Its Resource Expansion Drilling Program at Philibert
Northern Superior Resources Inc. announces positive results from the expansion drilling campaign at the Philibert gold property near Chibougamau, Quebec. Significant mineralized intersections confirm potential resource expansion -
COMMUNIQUÉ DE PRESSE
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
Quantum BioPharma starts sentinel dosing for Lucid-21-302 trial in multiple sclerosis treatment. Corporate update includes engaging ITG, Buyins, and Stockjock for Investor Relations Activities -
-
COMMUNIQUÉ DE PRESSE
New California Law Accelerates SMX Technology to Scale Sustainability Efforts Across the U.S. and Globally
Discover how SMX technology is revolutionizing industries with verifiable sustainability solutions. From textiles to plastics, SMX's digital tracking ensures accountability and compliance -
-
-
COMMUNIQUÉ DE PRESSE
Wolfden Options Drill-Ready Nevada Gold Property in the Walker Lane Trend that hosts Several Bonanza and Large Epithermal Gold Systems
Wolfden Resources Corporation announces option agreement to earn interest in Rockland Property, targeting high-grade gold-silver system in Nevada's Walker Lane Trend -
COMMUNIQUÉ DE PRESSE
Pentixapharm Holding AG: US National Cancer Institute Starts Advanced Clinical Trial with PentixaFor
US National Cancer Institute initiates clinical trial with PentixaFor, a new radioactive tracer, to aid in identifying adrenal tumors through PET scans, potentially benefiting patients with aldosteronism and Cushing's syndrome
